Biomarkers, subgroup evaluation, and clinical trial design.

Type: Article

Publication Date: 2012-03-01

Citations: 30

Locations

Similar Works

Action Title Year Authors
+ Futility for subgroup analyses in the adaptive signature design 2017 Andrea Callegaro
+ Biomarker adaptive designs in clinical trials 2014 James J. Chen
Tzu‐Pin Lu
Dung‐Tsa Chen
Sue-Jane Wang
+ Practical Considerations for Subgroups Quantification, Selection and Adaptive Enrichment in Confirmatory Trials 2019 Jianchang Lin
Veronica Bunn
Rachael Liu
+ PDF Chat Clinical Trials for Personalized Medicine: Design and Data Analysis 2022 Shigeyuki Matsui
+ Personalized medicine: challenges in biomarker-related clinical trial design 2015 Pei He
+ PDF Chat Subgroup identification for treatment selection in biomarker adaptive design 2015 Tzu‐Pin Lu
James J. Chen
+ Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek 2023 Lisa M. McShane
Mark Rothmann
Thomas R. Fleming
+ PDF Chat Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review 2016 Miranta Antoniou
Andrea Jorgensen
Ruwanthi Kolamunnage‐Dona
+ Identification of biomarker-defined populations in precision medicine 2023 Cynthia Huber
+ Personalized Medicine: Four Perspectives of Tailored Medicine 2015 Stephen J. Ruberg
Lei Shen
+ Study Designs for Clinical Trial using Biomarker 2012 Sohei Yamamoto
+ Adaptive Biomarker Enrichment Design Through Threshold Identification for Multi-Dose Clinical Trials 2022 Xizhi Luo
Man Jin
Xin Huang
+ PDF Chat Adaptive enrichment in biomarker-stratified clinical trial design 2013 Deepak Parashar
Jack Bowden
Colin Starr
Lorenz Wernisch
Adrian Mander
+ PDF Chat Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case Studies 2019 Fang‐Shu Ou
Ming-Wen An
Amy S. Ruppert
Sumithra J. Mandrekar
+ PDF Chat Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review 2017 Miranta Antoniou
Ruwanthi Kolamunnage‐Dona
Andrea Jorgensen
+ PDF Chat Estimating the subgroup and testing for treatment effect in a post-hoc analysis of a clinical trial with a biomarker 2019 Neha Joshi
Jason P. Fine
Rong Chu
Anastasia Ivanova
+ Predictive Biomarkers for Treatment Selection: Statistical Considerations 2015 James J. Chen
Tzu‐Pin Lu
Yu‐Chuan Chen
Wei‐Jiun Lin
+ Biomarker-Defined Subgroup Selection Adaptive Design for Phase III Confirmatory Trial with Time-to-Event Data: Comparing Group Sequential and Various Adaptive Enrichment Designs 2017 Rui Tang
Xiaoye Ma
Hui Yang
Michael Wolf
+ Development of predictive signatures for treatment selection in precision medicine with survival outcomes 2018 Yu‐Chuan Chen
Un Jung Lee
Chen‐An Tsai
James J. Chen
+ Supplemental Material 1: Proposed marker-stratified design from Biomarker-Stratified Phase III Clinical Trials: Enhancement with a Subgroup-Focused Sequential Design 2023 Shigeyuki Matsui
John Crowley

Works Cited by This (0)

Action Title Year Authors